Healthcare >> CEO Interviews >> January 10, 2001
MAHENDRA G. SHAH, PhD, is the Chairman of the Board and Chief Executive
Officer of First Horizon Pharmaceutical_ Corporation. Dr. Shah has been
a Director since 1993 and his present term as Director will expire in
2001. Dr. Shah became Chief Executive Officer in October 1999. He
maintains other employment and expects to dedicate the majority of his
working time to the company. From 1991 to the present, he has been the
Vice President of EJ Financial Enterprises, Inc., which manages a fund
that invests in healthcare companies. From 1996 to the present, he has
been the President of ProtoMed, Pharmaceuticals, Inc., which is a
privately held drug development company. From 1987 to 1991 he was the
Senior Director of New Business Development with Fujisawa USA, Inc.
Prior to that time, he worked in various scientific and management
positions with Schering-Plough and Bristol-Myers Squibb Company. He
serves on the Board of Introgen Therapeutics, Inc., and Structural
Bioinformatics, Inc. He previously served on the Board of Unimed
Pharmaceuticals (UMED). Dr. Shah received his PhD in Industrial Pharmacy
from St. John's University, and his Bachelor's and Master's degrees in
Pharmacy from L.M. College of Pharmacy in Gujarat, India. Profile
Dr. Shah: First Horizon is a specialty pharmaceutical company focused on
high prescribing, primary care physicians and
